Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Baboudjian

Showing results (1-10 of 178) with videos related to

Pageof 18
Sort By:
European Urology Oncology|May 23, 2025
Reply to Isabel Heidegger and Jasmin Bektic's Letter to the Editor re: Michael Baboudjian, Riccardo Leni, Marco Oderda, et al., Active Surveillance of Grade Group 2 Prostate Cancer: Oncological Outcomes from a Contemporary European Cohort. Eur Urol Oncol. 2025;8:1257-1263Michael Baboudjian, Guillaume Ploussard
BJU International|October 20, 2022
Re: "Rezūm therapy for ≥ 80 mL benign prostatic enlargement: a large, multicentre cohort study"Michael Baboudjian, Marc Fourmarier
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|August 30, 2021
[Office-based therapies for benign prostatic hyperplasia : Update on new minimally invasive surgery therapies]Michael Baboudjian, Benjamin Pradere
The Journal of Urology|October 10, 2022
Gleason Grade 1 Prostate Cancer Volume at Biopsy Is Associated With Upgrading, but Not Adverse Pathology or Recurrence After Radical Prostatectomy: Results From a Large Institutional Cohort. LetterMichael Baboudjian, Guillaume Ploussard
Journal of Endourology|July 16, 2021
Response to Editorial Comment: "Primary Complete Transurethral Resection of Bladder Tumor Using Photodynamic Diagnosis for High-risk Nonmuscle Invasive Bladder Cancer: Is a Restaging Photodynamic Transurethral Resection Really Necessary?" by Tadrist et alMichael Baboudjian, Abel Tadrist, Eric Lechevallier
European Urology|June 23, 2022
Re: Benjamin Pradere, Richard Mallet, Alexandre de La Taille, et al. Climate-smart Actions in the Operating Theatre for Improving Sustainability Practices: A Systematic Review. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2022.01.027Michael Baboudjian, Pietro Diana, Alberto Breda
European Urology Focus|November 8, 2023
How Best to Implement Climate-smart Actions in Clinical Urologic CareBenjamin Pradere, Vincent Misraï, Michael Baboudjian
European Urology|September 25, 2025
Re: Fabian P. Stangl, Isabel Heidegger, Pia Kraft, et al. Challenging the Urologist of the Future: Time for a Change? Eur Urol. In press. https://doi.org/10.1016/j.eururo.2024.05.018Arthur Peyrottes, Richard Mallet, Michael Baboudjian
The French Journal of Urology|April 10, 2024
Con: Preoperative urodynamics still has a role for BPH patients after the UPSTREAM trialMichael Baboudjian, Alessandro Uleri, Benjamin Pradere
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 2, 2022
Redefining Gleason 6 Prostate Cancer Nomenclature: The Surgeon's PerspectiveMichael Baboudjian, Morgan Rouprêt, Guillaume Ploussard
Pageof 18

Showing results (1-10 of 178) with videos related to

Sort By:
Pageof 18
European Urology Oncology|May 23, 2025
Reply to Isabel Heidegger and Jasmin Bektic's Letter to the Editor re: Michael Baboudjian, Riccardo Leni, Marco Oderda, et al., Active Surveillance of Grade Group 2 Prostate Cancer: Oncological Outcomes from a Contemporary European Cohort. Eur Urol Oncol. 2025;8:1257-1263Michael Baboudjian, Guillaume Ploussard
BJU International|October 20, 2022
Re: "Rezūm therapy for ≥ 80 mL benign prostatic enlargement: a large, multicentre cohort study"Michael Baboudjian, Marc Fourmarier
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|August 30, 2021
[Office-based therapies for benign prostatic hyperplasia : Update on new minimally invasive surgery therapies]Michael Baboudjian, Benjamin Pradere
The Journal of Urology|October 10, 2022
Gleason Grade 1 Prostate Cancer Volume at Biopsy Is Associated With Upgrading, but Not Adverse Pathology or Recurrence After Radical Prostatectomy: Results From a Large Institutional Cohort. LetterMichael Baboudjian, Guillaume Ploussard
Journal of Endourology|July 16, 2021
Response to Editorial Comment: "Primary Complete Transurethral Resection of Bladder Tumor Using Photodynamic Diagnosis for High-risk Nonmuscle Invasive Bladder Cancer: Is a Restaging Photodynamic Transurethral Resection Really Necessary?" by Tadrist et alMichael Baboudjian, Abel Tadrist, Eric Lechevallier
European Urology|June 23, 2022
Re: Benjamin Pradere, Richard Mallet, Alexandre de La Taille, et al. Climate-smart Actions in the Operating Theatre for Improving Sustainability Practices: A Systematic Review. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2022.01.027Michael Baboudjian, Pietro Diana, Alberto Breda
European Urology Focus|November 8, 2023
How Best to Implement Climate-smart Actions in Clinical Urologic CareBenjamin Pradere, Vincent Misraï, Michael Baboudjian
European Urology|September 25, 2025
Re: Fabian P. Stangl, Isabel Heidegger, Pia Kraft, et al. Challenging the Urologist of the Future: Time for a Change? Eur Urol. In press. https://doi.org/10.1016/j.eururo.2024.05.018Arthur Peyrottes, Richard Mallet, Michael Baboudjian
The French Journal of Urology|April 10, 2024
Con: Preoperative urodynamics still has a role for BPH patients after the UPSTREAM trialMichael Baboudjian, Alessandro Uleri, Benjamin Pradere
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 2, 2022
Redefining Gleason 6 Prostate Cancer Nomenclature: The Surgeon's PerspectiveMichael Baboudjian, Morgan Rouprêt, Guillaume Ploussard
Pageof 18